ETF constituents for BMED

Below, a list of constituents for BMED (iShares Health Innovation Active ETF) is shown. In total, BMED consists of 54 securities.

Note: The data shown here is as of date Feb 28, 2026 (the latest that can be sourced directly from the fund provider).

Click here to go back to the full list of ETFs.

Ticker Name Sector Asset Class Market Value Weight (%)
JNJ JOHNSON & JOHNSON Health Care Equity 814322.42 7.86
XTSLA BLK CSH FND TREASURY SL AGENCY Cash and/or Derivatives Money Market 710000.0 6.85
MRK MERCK & CO INC Health Care Equity 575363.4 5.55
GILD GILEAD SCIENCES INC Health Care Equity 564515.58 5.45
AMGN AMGEN INC Health Care Equity 465417.95 4.49
EW EDWARDS LIFESCIENCES CORP Health Care Equity 463448.02 4.47
MCK MCKESSON CORP Health Care Equity 389729.25 3.76
BIIB BIOGEN INC Health Care Equity 320470.92 3.09
2269 WUXI BIOLOGICS CAYMAN INC Health Care Equity 315768.4 3.05
VRTX VERTEX PHARMACEUTICALS INC Health Care Equity 308469.66 2.98
WAT WATERS CORP Health Care Equity 307157.12 2.97
MRNA MODERNA INC Health Care Equity 305124.46 2.95
MTD METTLER TOLEDO INC Health Care Equity 305045.75 2.95
CRL CHARLES RIVER LABORATORIES INTERNA Health Care Equity 290473.39 2.8
DHR DANAHER CORP Health Care Equity 256956.95 2.48
ISRG INTUITIVE SURGICAL INC Health Care Equity 254259.18 2.45
ARGX ARGENX SE ADR Health Care Equity 251635.05 2.43
NOVN NOVARTIS AG Health Care Equity 234193.51 2.26
DXCM DEXCOM INC Health Care Equity 229261.2 2.21
BRKR BRUKER CORP Health Care Equity 224573.4 2.17
GSK WI GSK AMERICAN DEPOSITORY SHARES REP Health Care Equity 210868.5 2.04
PTGX PROTAGONIST THERAPEUTICS INC Health Care Equity 207994.14 2.01
TECH BIO TECHNE CORP Health Care Equity 196849.84 1.9
INSM INSMED INC Health Care Equity 193099.62 1.86
GH GUARDANT HEALTH INC Health Care Equity 178701.12 1.73
ROP ROCHE PS PAR AG Health Care Equity 172610.84 1.67
UCB UCB SA Health Care Equity 168913.32 1.63
AZN ASTRAZENECA PLC Health Care Equity 160753.26 1.55
COGT COGENT BIOSCIENCES INC Health Care Equity 157461.0 1.52
PFE PFIZER INC Health Care Equity 155932.48 1.51
GALD GALDERMA GROUP N AG Health Care Equity 154350.39 1.49
BSX BOSTON SCIENTIFIC CORP Health Care Equity 153097.32 1.48
INCY INCYTE CORP Health Care Equity 148951.45 1.44
IDXX IDEXX LABORATORIES INC Health Care Equity 144505.72 1.4
BMRN BIOMARIN PHARMACEUTICAL INC Health Care Equity 124466.01 1.2
TEVA TEVA PHARMACEUTICAL INDUSTRIES ADR Health Care Equity 97954.5 0.95
SMMT SUMMIT THERAPEUTICS INC Health Care Equity 61785.36 0.6
MDLN MEDLINE INC CLASS A Health Care Equity 61146.11 0.59
VRDN VIRIDIAN THERAPEUTICS ORS INC Health Care Equity 54120.15 0.52
DNTH DIANTHUS THERAPEUTICS INC Health Care Equity 50870.79 0.49
RVMD REVOLUTION MEDICINES INC Health Care Equity 49785.12 0.48
BNTX BIONTECH SE ADR Health Care Equity 44207.46 0.43
EIKN EIKON THERAPEUTICS INC Health Care Equity 13870.71 0.13
AKTS AKTIS ONCOLOGY INC Health Care Equity 11128.08 0.11
nan ABIOMED CVRS Health Care Equity 570.72 0.01
MRTX MIRATI THERAPEUTICS INC Health Care Equity 263.86 0.0
GBP GBP CASH Cash and/or Derivatives Cash 170.41 0.0
nan BLUEPRINT MEDICINES CORP Health Care Equity 110.0 0.0
DUMMY VIGIL NEUROSCIENCE INC CVR Health Care Equity 24.2 0.0
EUR EUR CASH Cash and/or Derivatives Cash 1.75 0.0
KRW KRW CASH Cash and/or Derivatives Cash 0.01 0.0
KRRBIO KORRO BIO INC CVR Health Care Equity 0.0 0.0
USD USD CASH Cash and/or Derivatives Cash -202731.59 -1.96
The content contained herein is owned or licensed by BlackRock and/or its third-party information providers and is protected by applicable copyrights, trademarks, service marks, and/or other intellectual property rights. Such content is solely for your personal, non-commercial use. Accordingly, you may not copy, distribute, modify, post, frame or deep link this content. You may download material displayed on this Website for your personal use provided you also retain all copyright and other proprietary notices contained on the materials. Modification or use of the materials for any other purpose violates BlackRock's intellectual property rights. Holdings subject to change. See www.iShares.com for the most recent funds holdings. The values for “price” shown herein generally represent a price provided by a third-party pricing vendor for the portfolio holding and do not reflect the impact of systematic fair valuation (“the vendor price”). The vendor price is not necessarily the price at which the Fund values the portfolio holding for the purposes of determining its net asset value (the “valuation price”). Additionally, where applicable, foreign currency exchange rates with respect to the portfolio holdings denominated in non-U.S. currencies for the valuation price will be generally determined as of the close of business on the New York Stock Exchange, whereas for the vendor price will be generally determined as of 4 p.m. London. The values shown herein for “market value,” “weight,” and “notional value” (the “calculated values”) are based off of the vendor price and may have been different if the valuation price were to have been used to calculate such values. The vendor price is as of the most recent practicable date and may not necessarily be as of the date shown above. Please see the “Determination of Net Asset Value” section of each Fund’s prospectus for additional information on the Fund’s valuation policies and procedures. CAREFULLY CONSIDER THE FUNDS' INVESTMENT OBJECTIVES, RISK FACTORS, AND CHARGES AND EXPENSES BEFORE INVESTING. THIS AND OTHER INFORMATION CAN BE FOUND IN THE FUNDS' PROSPECTUSES OR, IF AVAILABLE, THE SUMMARY PROSPECTUSES WHICH MAY BE OBTAINED BY VISITING WWW.ISHARES.COM OR WWW.BLACKROCK.COM. READ THE PROSPECTUS CAREFULLY BEFORE INVESTING. INVESTING INVOLVES RISK, INCLUDING POSSIBLE LOSS OF PRINCIPAL. This information should not be relied upon as research, investment advice, or a recommendation regarding any products, strategies, or any security in particular. This material is strictly for illustrative, educational, or informational purposes and is subject to change. The Funds are distributed by BlackRock Investments, LLC (together with its affiliates, “BlackRock”). The iShares Funds are not sponsored, endorsed, issued, sold or promoted by Bloomberg, BlackRock Index Services, LLC, Cboe Global Indices, LLC, Cohen & Steers, European Public Real Estate Association (“EPRA® ”), FTSE International Limited (“FTSE”), ICE Data Indices, LLC, NSE Indices Ltd, JPMorgan, JPX Group, London Stock Exchange Group (“LSEG”), MSCI Inc., Markit Indices Limited, Morningstar, Inc., Nasdaq, Inc., National Association of Real Estate Investment Trusts (“NAREIT”), Nikkei, Inc., Russell, S&P Dow Jones Indices LLC or STOXX Ltd. None of these companies make any representation regarding the advisability of investing in the Funds. With the exception of BlackRock Index Services, LLC, who is an affiliate, BlackRock Investments, LLC is not affiliated with the companies listed above. Neither FTSE, LSEG, nor NAREIT makes any warranty regarding the FTSE Nareit Equity REITS Index, FTSE Nareit All Residential Capped Index or FTSE Nareit All Mortgage Capped Index. Neither FTSE, EPRA, LSEG, nor NAREIT makes any warranty regarding the FTSE EPRA Nareit Developed ex-U.S. Index, FTSE EPRA Nareit Developed Green Target Index or FTSE EPRA Nareit Global REITs Index. “FTSE®” is a trademark of London Stock Exchange Group companies and is used by FTSE under license. ©2023 BlackRock, Inc or its affiliates. All rights reserved. iSHARES, iBONDS and BLACKROCK are trademarks of BlackRock, Inc. or its affiliates. All other trademarks are those of their respective owners. nan nan nan nan nan